STOCK TITAN

[144] Twist Bioscience Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

The Form 144 filed for TWST reports a proposed sale of 2,716 shares of common stock through Fidelity Brokerage Services on 08/21/2025 with an aggregate market value of $70,518.77. The shares were acquired on 08/20/2025 via restricted stock vesting from the issuer and payment is noted as compensation. The filing also lists five sales by Emily M. Leproust in the past three months totaling 12,711 shares with combined gross proceeds of $398,886.65 on dates from 05/21/2025 through 08/04/2025. The notice includes the standard signature representation about absence of undisclosed material adverse information.

Il Modulo 144 presentato per TWST segnala una proposta di vendita di 2.716 azioni ordinarie tramite Fidelity Brokerage Services in data 21/08/2025 per un valore di mercato complessivo di $70.518,77. Le azioni sono state acquisite il 20/08/2025 mediante vestizione di azioni soggette a restrizioni dall'emittente e il pagamento è indicato come compenso. La segnalazione riporta inoltre cinque vendite effettuate da Emily M. Leproust negli ultimi tre mesi per un totale di 12.711 azioni con un ricavo lordo complessivo di $398.886,65 in date comprese tra 21/05/2025 e 04/08/2025. L'avviso include la consueta dichiarazione firmata riguardo all'assenza di informazioni materiali sfavorevoli non comunicate.

El Formulario 144 presentado para TWST informa una propuesta de venta de 2.716 acciones ordinarias a través de Fidelity Brokerage Services el 21/08/2025 por un valor de mercado agregado de $70.518,77. Las acciones fueron adquiridas el 20/08/2025 mediante consolidación de acciones restringidas por parte del emisor y el pago se indica como compensación. La presentación también enumera cinco ventas realizadas por Emily M. Leproust en los últimos tres meses que suman 12.711 acciones con ingresos brutos combinados de $398.886,65 en fechas desde el 21/05/2025 hasta el 04/08/2025. El aviso incluye la representación de firma estándar sobre la ausencia de información material adversa no divulgada.

TWST에 대해 제출된 Form 144는 2025-08-21에 Fidelity Brokerage Services를 통해 보통주 2,716주를 매도할 예정이며 총 시가가 $70,518.77라고 보고합니다. 해당 주식은 발행사로부터의 제한주(restricted stock) 베스팅으로 2025-08-20에 취득되었고 지급 사유는 보수(Compensation)로 표시되어 있습니다. 제출 서류에는 또한 Emily M. Leproust가 지난 세 달 동안 총 12,711주를 매도하여 합산 총수익이 $398,886.65에 이르는 다섯 건의 매도 내역(기간: 2025-05-21부터 2025-08-04까지)이 기재되어 있습니다. 이 통지에는 미공개된 중대한 불리한 정보가 없다는 표준 서명 진술도 포함되어 있습니다.

Le formulaire 144 déposé pour TWST signale une proposition de vente de 2 716 actions ordinaires via Fidelity Brokerage Services le 21/08/2025, pour une valeur de marché totale de 70 518,77 $. Les actions ont été acquises le 20/08/2025 par vesting d'actions restreintes émis par l'émetteur et le paiement est indiqué comme rémunération. Le dépôt énumère également cinq ventes réalisées par Emily M. Leproust au cours des trois derniers mois, totalisant 12 711 actions pour un produit brut combiné de 398 886,65 $ aux dates du 21/05/2025 au 04/08/2025. L'avis inclut la déclaration signée standard concernant l'absence d'informations défavorables importantes non divulguées.

Das für TWST eingereichte Formular 144 meldet einen geplanten Verkauf von 2.716 Stammaktien über Fidelity Brokerage Services am 21.08.2025 mit einem Gesamtmarktwert von $70.518,77. Die Aktien wurden am 20.08.2025 durch Vesting eingeschränkter Aktien vom Emittenten erworben und die Zahlung ist als Vergütung angegeben. Die Einreichung listet außerdem fünf Verkäufe von Emily M. Leproust in den letzten drei Monaten auf, die insgesamt 12.711 Aktien mit kombinierten Bruttoerlösen von $398.886,65 umfassen, datiert von 21.05.2025 bis 04.08.2025. Die Mitteilung enthält die übliche unterzeichnete Darstellung über das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Notice documents a small proposed sale following restricted stock vesting and multiple recent disposals by the same seller.

The filing shows a proposed sale of 2,716 shares acquired one day earlier by restricted stock vesting and designated as compensation. The seller, Emily M. Leproust, completed five prior sales in the preceding three months totaling 12,711 shares and roughly $398,887 in gross proceeds. Relative to the reported outstanding share count of 60,360,925, these transactions represent a de minimis percentage of outstanding stock. From a market-impact perspective the sizes are small; the filing primarily serves regulatory disclosure of intended insider sales under Rule 144.

TL;DR: Form 144 furnishes required disclosure for proposed Rule 144 sales tied to recently vested restricted stock.

The document provides required particulars: broker, share counts, acquisition date and nature (restricted stock vesting), and prior sales in the three‑month lookback. It includes the signer’s representation about lack of undisclosed material adverse information. The filing appears to meet the informational elements expected for a Rule 144 notice; no regulatory deficiencies are stated within the text provided.

Il Modulo 144 presentato per TWST segnala una proposta di vendita di 2.716 azioni ordinarie tramite Fidelity Brokerage Services in data 21/08/2025 per un valore di mercato complessivo di $70.518,77. Le azioni sono state acquisite il 20/08/2025 mediante vestizione di azioni soggette a restrizioni dall'emittente e il pagamento è indicato come compenso. La segnalazione riporta inoltre cinque vendite effettuate da Emily M. Leproust negli ultimi tre mesi per un totale di 12.711 azioni con un ricavo lordo complessivo di $398.886,65 in date comprese tra 21/05/2025 e 04/08/2025. L'avviso include la consueta dichiarazione firmata riguardo all'assenza di informazioni materiali sfavorevoli non comunicate.

El Formulario 144 presentado para TWST informa una propuesta de venta de 2.716 acciones ordinarias a través de Fidelity Brokerage Services el 21/08/2025 por un valor de mercado agregado de $70.518,77. Las acciones fueron adquiridas el 20/08/2025 mediante consolidación de acciones restringidas por parte del emisor y el pago se indica como compensación. La presentación también enumera cinco ventas realizadas por Emily M. Leproust en los últimos tres meses que suman 12.711 acciones con ingresos brutos combinados de $398.886,65 en fechas desde el 21/05/2025 hasta el 04/08/2025. El aviso incluye la representación de firma estándar sobre la ausencia de información material adversa no divulgada.

TWST에 대해 제출된 Form 144는 2025-08-21에 Fidelity Brokerage Services를 통해 보통주 2,716주를 매도할 예정이며 총 시가가 $70,518.77라고 보고합니다. 해당 주식은 발행사로부터의 제한주(restricted stock) 베스팅으로 2025-08-20에 취득되었고 지급 사유는 보수(Compensation)로 표시되어 있습니다. 제출 서류에는 또한 Emily M. Leproust가 지난 세 달 동안 총 12,711주를 매도하여 합산 총수익이 $398,886.65에 이르는 다섯 건의 매도 내역(기간: 2025-05-21부터 2025-08-04까지)이 기재되어 있습니다. 이 통지에는 미공개된 중대한 불리한 정보가 없다는 표준 서명 진술도 포함되어 있습니다.

Le formulaire 144 déposé pour TWST signale une proposition de vente de 2 716 actions ordinaires via Fidelity Brokerage Services le 21/08/2025, pour une valeur de marché totale de 70 518,77 $. Les actions ont été acquises le 20/08/2025 par vesting d'actions restreintes émis par l'émetteur et le paiement est indiqué comme rémunération. Le dépôt énumère également cinq ventes réalisées par Emily M. Leproust au cours des trois derniers mois, totalisant 12 711 actions pour un produit brut combiné de 398 886,65 $ aux dates du 21/05/2025 au 04/08/2025. L'avis inclut la déclaration signée standard concernant l'absence d'informations défavorables importantes non divulguées.

Das für TWST eingereichte Formular 144 meldet einen geplanten Verkauf von 2.716 Stammaktien über Fidelity Brokerage Services am 21.08.2025 mit einem Gesamtmarktwert von $70.518,77. Die Aktien wurden am 20.08.2025 durch Vesting eingeschränkter Aktien vom Emittenten erworben und die Zahlung ist als Vergütung angegeben. Die Einreichung listet außerdem fünf Verkäufe von Emily M. Leproust in den letzten drei Monaten auf, die insgesamt 12.711 Aktien mit kombinierten Bruttoerlösen von $398.886,65 umfassen, datiert von 21.05.2025 bis 04.08.2025. Die Mitteilung enthält die übliche unterzeichnete Darstellung über das Fehlen nicht offengelegter wesentlicher nachteiliger Informationen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the TWST Form 144 propose to sell?

The notice proposes to sell 2,716 shares of TWST common stock through Fidelity on 08/21/2025 with an aggregate market value of $70,518.77.

How were the shares being sold on Form 144 acquired?

The shares were acquired on 08/20/2025 via restricted stock vesting from the issuer, and the payment nature is listed as compensation.

Who sold shares of TWST in the past three months and how many?

Emily M. Leproust sold 12,711 shares during the past three months on five dates (05/21/2025, 06/06/2025, 06/20/2025, 07/02/2025, 08/04/2025) for combined gross proceeds of $398,886.65.

Through which broker is the proposed sale to occur?

The proposed sale is to occur through Fidelity Brokerage Services LLC, with the filing listing an address at 900 Salem Street, Smithfield, RI.

What outstanding share count is reported in the filing?

The filing reports 60,360,925 shares outstanding for the issuer.
Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Latest SEC Filings

TWST Stock Data

1.60B
59.18M
1.88%
116.82%
17.29%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO